Literature DB >> 8335401

Expression of the c-erbB-3 gene product in gastric cancer.

E E Sanidas1, M I Filipe, J Linehan, N R Lemoine, W J Gullick, T Rajkumar, D A Levison.   

Abstract

The pattern of c-erbB-3 gene product was studied in 91 advanced gastric carcinomas, adjacent hyperplastic mucosa, intestinal metaplasia and dysplasia and in normal controls, using immunohistochemistry in archival material. All tumours showed positive c-erbB-3 staining in both cytoplasm and membrane. No significant differences of expression were observed between intestinal and diffuse-type carcinomas or any other clinical parameters. Of interest is the expression in the adjacent mucosa, which is extensive, cytoplasmic, and of lower intensity than in the tumours. Further studies are currently being carried out to clarify the role of this protein in tumour behaviour and gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335401     DOI: 10.1002/ijc.2910540612

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Identification of ErbB3-stimulated genes using modified representational difference analysis.

Authors:  C F Edman; S A Prigent; A Schipper; J R Feramisco
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

2.  HER3 overexpression is a prognostic indicator of extrahepatic cholangiocarcinoma.

Authors:  Hee Jin Lee; Joon-Yong Chung; Stephen M Hewitt; Eunsil Yu; Seung-Mo Hong
Journal:  Virchows Arch       Date:  2012-10-02       Impact factor: 4.064

Review 3.  The type I growth factor receptors in human breast cancer.

Authors:  T Rajkumar; W J Gullick
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

4.  c-erbB3 protein expression in ovarian cancer.

Authors:  T Rajkumar; G W Stamp; C M Hughes; W J Gullick
Journal:  Clin Mol Pathol       Date:  1996-08

Review 5.  Targeting the human EGFR family in esophagogastric cancer.

Authors:  Alicia Okines; David Cunningham; Ian Chau
Journal:  Nat Rev Clin Oncol       Date:  2011-04-05       Impact factor: 66.675

6.  Comparative study on overexpression of HER2/neu and HER3 in gastric cancer.

Authors:  Xiu Li Zhang; Yun Sheng Yang; Dong Ping Xu; Jian Hui Qu; Ming Zhou Guo; Yan Gong; Jin Huang
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

Review 7.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

8.  A flow cytometric study of c-erbB-3 expression in breast cancer.

Authors:  I Brotherick; B K Shenton; B Angus; I S Waite; C H Horne; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

9.  A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.

Authors:  T Rajkumar; W J Gullick
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640

10.  Expression of c-erbB3 protein in primary breast carcinomas.

Authors:  R Naidu; M Yadav; S Nair; M K Kutty
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.